Obstructive sleep apnoe and cardiovascular, heart failure and mortality outcomes with empagliflozin versus placebo in the EMPA-REG OUTCOME trial
1 September 2020 (11:53 - 12:00)
Organised by:
About the speaker
New Haven (United States of America)
1 More presentation in this session
Access the full session
The Event
ESC Congress 2020
1 September 2020
11:53 CET
You may be interested in
Congress Presentation
Congress Presentation
